POZ - Treatment News : “Quad” HIV Pill Enters Phase II Study

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » April 2009

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


email print

April 20, 2009

“Quad” HIV Pill Enters Phase II Study

Gilead Sciences Inc. announced today it initiated a Phase II study of a new four-in-one—or “Quad”—HIV treatment. The Quad pill includes Gilead’s experimental integrase inhibitor called elvitegravir, an experimental boosting agent called GS 9350 and the approved drugs Viread (tenofovir) and Emtriva (emtricitabine).

The study will enroll 75 HIV-positive people who’ve never taken antiretroviral therapy before and will randomize them to take either the Quad pill or Atripla (efavirenz, tenofovir and emtricitabine). The 48-week trial will determine both the efficacy and the safety of the Quad pill after 24 and 48 weeks of treatment.

The study is not so much to evaluate the efficacy and safety of elvitegravir—which has already successfully completed a Phase II study and is now in two large Phase III studies—as much as to test the new blood level boosting agent GS 9350, which is being examined as an alternative for low-dose Norvir (ritonavir).

Search: Quad pill, elvitegravir, GS9350, integrase inhibitor, booster, Norvir, ritonavir, Viread, tenofovir, Emtriva, emtricitabine, Atripla, efavirenz, Gilead Sciences


Scroll down to comment on this story.

email print

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

  comments 1 - 4 (of 4 total)    

christina l diamond, kewaskum, wi, 2009-05-25 21:55:08
i hope it helps alot of people!!!

Tim Horn, AIDSmeds.com, New York, NY, 2009-04-24 15:29:52
pablo - this is essentially a single pill containing four drugs, arguably easier to take than handfulls of pills. Please understand that it's just now going into intermediate studies, so we can't so much about its safety or effectiveness.

pabloMontagna, Newport Beach, CA, 2009-04-24 14:27:29
Don't TeASE ME... your article “Quad” HIV Pill Enters Phase II Study is stingy. Tell me what is it for, how is it better, why its been tested, Who is it conna help. How does it interact against virus?(simple wording) What are "they" looking to accomplish? Why? C'mon guys of POZ.. give us the whole enchilada man!!

RJ, Orange County CA, 2009-04-21 13:08:05
I can't help but notice that I don't see any PIs except for Norvir (the booster.) I have become resistant to all nukes and non-nukes over the past 25 years. I guess this wouldn't work for me. Boo.

comments 1 - 4 (of 4 total)    


[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar
Starting Treatment
Quilt in the Capital
POZ Army


    adoniz89
    san dimas
    California


    UPPinAction
    New Brunswick
    New Jersey


    sefarady
    Los Angeles
    California


    donnyp
    liberty
    Kentucky
Click here to join POZ Personals!
Talk to Us
Poll
Do you support rapid in-home HIV testing?
Yes
No

Survey
Health 2.0

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.